Student Spotlight

Nam_Hyungwoo

Hyungwoo Nam

Thesis Title: Early Life Experiences and Brain Circuits that Mediate Stress Responses
Mentor: Illan Kerman, MD
Department: Psychiatry – Behavioral Neurobiology
Undergrad: BS, Yonsei University, South Korea

Welcome to the Cell, Molecular, and Developmental Biology (CMDB) PhD Theme, a part of the Graduate Biomedical Sciences program at the University of Alabama at Birmingham School of Medicine. The CMDB theme is designed to provide maximum flexibility that results in students who are prepared to launch into a career in the emerging biomedical science field. Our graduates have exciting careers in scientific research in both academic and industrial settings; scientific-related writing, business, law, bioterrorism, forensics, administration, and education. 

About Us: CMDB is a cross-disciplinary theme at a leading research University in the sunny south, consisting of a diverse group of scientists and physicians who have a collective interest in fundamental processes in cell, molecular, and developmental biology and how alterations in these processes result inhuman diseases and birth defects.

About UAB: We are consistently one of the top 25 NIH funded research institutions in the U.S. and with faculty from over 30 departments across campus there are many opportunities for you in new and exciting areas of biomedical research. And, UAB is a leader in innovative technology such as whole genome sequencing, electron microscopy, mass spectrometry, crystallography, flow cytometry, drug discovery and others.

Contact Us: We are always searching for the brightest and most dedicated students to join our highly competitive CMDB theme and experience firsthand our cutting edge science. This is your personal invitation to explore the many possible opportunities offered by CMDB at UAB. Please explore this web site and apply today!
No events found
GCalendar
  • Convergence insufficiency can be mistaken for attention deficit disorder because the inability to focus eyesight can lead to reading and attention problems.Kristine Hopkins and pediatric clinic patient. Photo by Nik Layman.Convergence insufficiency — the inability to keep both eyes working together — causes difficulties in the classroom for children and is often mistaken for attention deficit disorder due to an overlap in behaviors. The University of Alabama at Birmingham School of Optometry is part of a multicenter clinical trial todetermine what effects treatment of convergence insufficiency may have on reading comprehension and attention in these children. UAB is one of eight centers taking part in the convergence insufficiency treatment trial (CITT) study funded by an $8 million five-year grant from the National Institutes of Health’s National Eye Institute. “Children spend 75 percent of their school day reading and doing close work,” said Kristine Hopkins, O.D., MSPH, associate professor of optometry and site principal...

  • A UAB researcher focusing on the epigenetics of drug abuse wins a significant funding award from the National Institutes of Health.Jeremy DayJeremy J. Day, Ph.D., assistant professor in the Department of Neurobiology at the University of Alabama at Birmingham, has been named one of six inaugural recipients of new research awards from the National Institute on Drug Abuse. The Avenir Award programs in HIV/AIDS and epigenetics are newly developed programs that reward early-stage investigators who propose highly innovative studies. Avenir means ‘future’ in French. The Avenir Award Program for Genetics or Epigenetics of Substance Abuse supports early-stage investigators who show promise of being tomorrow’s leaders in the field of genetics or epigenetics of substance abuse. Epigenetics is an emerging field that studies how environmental factors influence changes in gene expression without altering the DNA sequence. Day says his proposal examines exposure to drugs of abuse, which produce long-lasting changes in neuronal circuits...

  • Male and female mice use different immune cells to process chronic pain, indicating that different therapies for different genders could better target the problem.New research by University of Alabama at Birmingham researcher Robert Sorge, Ph.D., and team published today in Nature Neuroscience online challenges the common belief that males and females process pain in the same way. The majority of existing research shows that men and women have different sensitivity to pain — women are more sensitive to pain overall — but the assumption has always been that a common pain circuit exists in both sexes that is altered by circulating hormones like estrogen. Sorge and colleagues from three laboratories in the United States and Canada found that this assumption may be false, and that males and females may use very different biological systems to process pain. The key sex difference appears to be in the immune system, and under control of...

Epi Menu